A tissue therapeutics revolution
CUTISS is a late-stage clinical TechBio company and a global leader in skin tissue therapeutics. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy which enables scaled, automated, and on-demand skin production.
Developed for patients requiring skin grafts due to a wide range of indications – from massive burns to reconstructive and aesthetic applications – denovoSkin™ has demonstrated safety and efficacy compared to the standard of care, with significantly improved scar quality.
Production
CUTISS manufactures its lead product for clinical use
in its state of the art, certified Good Manufacturing Practice Facility
in Schlieren near Zurich.
Automation
CUTISS has developed first-in-class machine for the automated production of tissue therapy. To secure scale-up, allow decentralization and achieve relevant cost reduction for the manufacturing of denovoSkin, CUTISS has been developing first-in-class automated bio-reactors with leading Swiss and international engineering partners. This pioneering, proprietary platform may also be used beyond skin for the next-priority human tissues (muscle, gums, etc.) in the future.
